StartupHub.ai — AI Ecosystem Hub

Discover

Home
Search
Trending
News
Rankings
Deals
Watchlist
Lists

Intelligence

Market Analysis
Comparison
Claude's Corner
Claude's Trades
Agentic Arbitrage
NEW

Tools

Market Map Maker
NEW
Visual TL;DR
MCP
YouTube to Article
NEW
Email Validator
MCP
AI Agent Readiness
Tech Stack Checker
NEW
Monitor
NEW
Social Poster
NEW
Deep Intelligence
NEW
Find Matches
NEW
Founder Game
NEW
API Docs

Company

Pricing
Solutions
Advertise
Publish Content
Affiliate Program
About
Terms
Privacy

Account

Home

Ayala Pharmaceuticals Post Ipo Merger

Loading exit event...

The leading intelligence layer for the startup ecosystem. Over 20,000 AI startups, curated, scored, and agent-ready, backed by 65M+ company profiles and 5B+ AI-enriched data points you can query in real time through our RAG API.

GDPR CCPA SSL Privacy MCP Ready RFC 9727 llms.txt Agent Skills

AI Daily Digest

Top AI & startup news each morning

+42k readers

Discover

Universal Search
Startups
Investors
People
Funding Rounds
Rankings
Trending
Lists
Companies by Tech

Free Tools

Email Validator
Email Finder
AI Agent Readiness
Market Map Maker
Watchlist
MCP Servers

For Founders & Devs

List via AI
NEW
Submit a Profile
Submit Article
Sell Your Startup
Pricing
Advertise
Embed Our Badge
Affiliate Program
NEW
API Docs
New Startups API
NEW
Agent Readiness Docs

Integrations

Setup wizard
NEW
All integrations
Clay
Zapier
n8n
Make
MCP Server

Company

AI News
About
Contact
Write for Us
Publish a Post · Newswire
Research
Terms of Service
Privacy Policy
Affiliate Disclosure

Compare

Crunchbase
PitchBook
CB Insights
Harmonic
Hunter
Apollo
Skrapp
Snov.io
Macabacus

© 2026 StartupHub.ai. All rights reserved. Terms · Privacy

security.txt RSS Sitemap

Biosight Post-IPO Merger

Biosight Post-IPO Merger

Ayala Pharmaceuticals Website

BP

Biosight Post-IPO Merger

Post-IPO Merger

2017

Ayala Pharmaceuticals Website

Profile section

About

No description available.

TypePost-IPO Merger

AcquirerAyala Pharmaceutical

AnnouncedOctober 2023

Company

Ayala Pharmaceuticals

Jerusalem, Israel

Deal details

TypePost-IPO Merger

AcquirerAyala Pharmaceutical

AnnouncedOct 19, 2023

Exit score

57/100

Solid

A solid exit with healthy economics.

Liquidity type
IPO — a clean public-market liquidity event.

Heuristic read of deal size vs peers, return multiple, acquirer premium, and liquidity type. Not investment advice.